Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes

The association of anti-MHC class I-related chain A (MICA) and kidney allograft rejection has been reported. However, the associations of antibodies specific to donor MICA (dsMICA) and dsMICA levels with allograft outcome have not been elucidated. From November 2009 to June 2017, 125 sera samples fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of clinical and laboratory science 2020-03, Vol.50 (2), p.247-252
Hauptverfasser: Lee, Nuri, Nam, Minjeong, Roh, Eun Youn, Shin, Sue, Park, Kyoung Un, Song, Eun Young
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 252
container_issue 2
container_start_page 247
container_title Annals of clinical and laboratory science
container_volume 50
creator Lee, Nuri
Nam, Minjeong
Roh, Eun Youn
Shin, Sue
Park, Kyoung Un
Song, Eun Young
description The association of anti-MHC class I-related chain A (MICA) and kidney allograft rejection has been reported. However, the associations of antibodies specific to donor MICA (dsMICA) and dsMICA levels with allograft outcome have not been elucidated. From November 2009 to June 2017, 125 sera samples from renal transplantation recipients with no HLA antibodies were screened for MICA antibodies. Patients with positive MICA antibody screening results and available residual donor DNA for MICA geno-typing underwent dsMICA analysis. Among these 125 sera samples, 19 were positive for MICA antibodies. dsMICA was positive in 5 out of the 12 analyzed sera samples. Neither MICA antibodies nor dsMICA were associated with acute rejection. However, interstitial fibrosis and tubular atrophy (IFTA) was significantly associated with MICA antibody positivity (OR=3.84, =0.009). In addition, the MFI value of dsMICA was significantly higher in patients with IFTA II or III than in patients without IFTA II or III ( =0.009). The association of MICA antibodies and dsMICA with high grade IFTA (grade II or III) was suggested. The MICA antibody and dsMICA might be useful indicators of chronic renal damage.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2398631438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2398631438</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-3a1018fde5b71fe9ba6e8153a515c9375fb09302d3298edf2d8f63440319a5763</originalsourceid><addsrcrecordid>eNo1kE9LwzAchoMgbk6_guQ4D4X8abLkWIq6wcZA9FzT5hcXSZvZpIjf3qHz9F4eHnjeCzSnQpBCEUVm6DqlD0KYLktyhWaccSmFLOforUopdt5kH4eEo8PVkH2xW9e4DiYlvClGCCaDxfXB-AFXeLnb1NX9L9dG6yHhL58P-BkGE3AVQnwfjct4P-Uu9pBu0KUzIcHteRfo9fHhpV4X2_3TSbQtjozSXHBDCVXOgmhX1IFujQRFBTeCik7zlXAt0Zwwy5lWYB2zykl-quFUG7GSfIGWf97jGD8nSLnpfeogBDNAnFLDuFaS05KrE3p3Rqe2B9scR9-b8bv5f4X_AKGBWsE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2398631438</pqid></control><display><type>article</type><title>Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lee, Nuri ; Nam, Minjeong ; Roh, Eun Youn ; Shin, Sue ; Park, Kyoung Un ; Song, Eun Young</creator><creatorcontrib>Lee, Nuri ; Nam, Minjeong ; Roh, Eun Youn ; Shin, Sue ; Park, Kyoung Un ; Song, Eun Young</creatorcontrib><description>The association of anti-MHC class I-related chain A (MICA) and kidney allograft rejection has been reported. However, the associations of antibodies specific to donor MICA (dsMICA) and dsMICA levels with allograft outcome have not been elucidated. From November 2009 to June 2017, 125 sera samples from renal transplantation recipients with no HLA antibodies were screened for MICA antibodies. Patients with positive MICA antibody screening results and available residual donor DNA for MICA geno-typing underwent dsMICA analysis. Among these 125 sera samples, 19 were positive for MICA antibodies. dsMICA was positive in 5 out of the 12 analyzed sera samples. Neither MICA antibodies nor dsMICA were associated with acute rejection. However, interstitial fibrosis and tubular atrophy (IFTA) was significantly associated with MICA antibody positivity (OR=3.84, =0.009). In addition, the MFI value of dsMICA was significantly higher in patients with IFTA II or III than in patients without IFTA II or III ( =0.009). The association of MICA antibodies and dsMICA with high grade IFTA (grade II or III) was suggested. The MICA antibody and dsMICA might be useful indicators of chronic renal damage.</description><identifier>EISSN: 1550-8080</identifier><identifier>PMID: 32366564</identifier><language>eng</language><publisher>United States</publisher><subject>Allografts ; Antibodies - blood ; Antibody Formation ; Female ; Graft Rejection - etiology ; Graft Rejection - pathology ; Graft Survival - immunology ; Histocompatibility Antigens Class I - immunology ; Humans ; Kidney Transplantation - adverse effects ; Male ; Middle Aged ; Prognosis ; Tissue Donors</subject><ispartof>Annals of clinical and laboratory science, 2020-03, Vol.50 (2), p.247-252</ispartof><rights>2020 by the Association of Clinical Scientists, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32366564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Nuri</creatorcontrib><creatorcontrib>Nam, Minjeong</creatorcontrib><creatorcontrib>Roh, Eun Youn</creatorcontrib><creatorcontrib>Shin, Sue</creatorcontrib><creatorcontrib>Park, Kyoung Un</creatorcontrib><creatorcontrib>Song, Eun Young</creatorcontrib><title>Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes</title><title>Annals of clinical and laboratory science</title><addtitle>Ann Clin Lab Sci</addtitle><description>The association of anti-MHC class I-related chain A (MICA) and kidney allograft rejection has been reported. However, the associations of antibodies specific to donor MICA (dsMICA) and dsMICA levels with allograft outcome have not been elucidated. From November 2009 to June 2017, 125 sera samples from renal transplantation recipients with no HLA antibodies were screened for MICA antibodies. Patients with positive MICA antibody screening results and available residual donor DNA for MICA geno-typing underwent dsMICA analysis. Among these 125 sera samples, 19 were positive for MICA antibodies. dsMICA was positive in 5 out of the 12 analyzed sera samples. Neither MICA antibodies nor dsMICA were associated with acute rejection. However, interstitial fibrosis and tubular atrophy (IFTA) was significantly associated with MICA antibody positivity (OR=3.84, =0.009). In addition, the MFI value of dsMICA was significantly higher in patients with IFTA II or III than in patients without IFTA II or III ( =0.009). The association of MICA antibodies and dsMICA with high grade IFTA (grade II or III) was suggested. The MICA antibody and dsMICA might be useful indicators of chronic renal damage.</description><subject>Allografts</subject><subject>Antibodies - blood</subject><subject>Antibody Formation</subject><subject>Female</subject><subject>Graft Rejection - etiology</subject><subject>Graft Rejection - pathology</subject><subject>Graft Survival - immunology</subject><subject>Histocompatibility Antigens Class I - immunology</subject><subject>Humans</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Tissue Donors</subject><issn>1550-8080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE9LwzAchoMgbk6_guQ4D4X8abLkWIq6wcZA9FzT5hcXSZvZpIjf3qHz9F4eHnjeCzSnQpBCEUVm6DqlD0KYLktyhWaccSmFLOforUopdt5kH4eEo8PVkH2xW9e4DiYlvClGCCaDxfXB-AFXeLnb1NX9L9dG6yHhL58P-BkGE3AVQnwfjct4P-Uu9pBu0KUzIcHteRfo9fHhpV4X2_3TSbQtjozSXHBDCVXOgmhX1IFujQRFBTeCik7zlXAt0Zwwy5lWYB2zykl-quFUG7GSfIGWf97jGD8nSLnpfeogBDNAnFLDuFaS05KrE3p3Rqe2B9scR9-b8bv5f4X_AKGBWsE</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Lee, Nuri</creator><creator>Nam, Minjeong</creator><creator>Roh, Eun Youn</creator><creator>Shin, Sue</creator><creator>Park, Kyoung Un</creator><creator>Song, Eun Young</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202003</creationdate><title>Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes</title><author>Lee, Nuri ; Nam, Minjeong ; Roh, Eun Youn ; Shin, Sue ; Park, Kyoung Un ; Song, Eun Young</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-3a1018fde5b71fe9ba6e8153a515c9375fb09302d3298edf2d8f63440319a5763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Allografts</topic><topic>Antibodies - blood</topic><topic>Antibody Formation</topic><topic>Female</topic><topic>Graft Rejection - etiology</topic><topic>Graft Rejection - pathology</topic><topic>Graft Survival - immunology</topic><topic>Histocompatibility Antigens Class I - immunology</topic><topic>Humans</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Tissue Donors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Nuri</creatorcontrib><creatorcontrib>Nam, Minjeong</creatorcontrib><creatorcontrib>Roh, Eun Youn</creatorcontrib><creatorcontrib>Shin, Sue</creatorcontrib><creatorcontrib>Park, Kyoung Un</creatorcontrib><creatorcontrib>Song, Eun Young</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of clinical and laboratory science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Nuri</au><au>Nam, Minjeong</au><au>Roh, Eun Youn</au><au>Shin, Sue</au><au>Park, Kyoung Un</au><au>Song, Eun Young</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes</atitle><jtitle>Annals of clinical and laboratory science</jtitle><addtitle>Ann Clin Lab Sci</addtitle><date>2020-03</date><risdate>2020</risdate><volume>50</volume><issue>2</issue><spage>247</spage><epage>252</epage><pages>247-252</pages><eissn>1550-8080</eissn><abstract>The association of anti-MHC class I-related chain A (MICA) and kidney allograft rejection has been reported. However, the associations of antibodies specific to donor MICA (dsMICA) and dsMICA levels with allograft outcome have not been elucidated. From November 2009 to June 2017, 125 sera samples from renal transplantation recipients with no HLA antibodies were screened for MICA antibodies. Patients with positive MICA antibody screening results and available residual donor DNA for MICA geno-typing underwent dsMICA analysis. Among these 125 sera samples, 19 were positive for MICA antibodies. dsMICA was positive in 5 out of the 12 analyzed sera samples. Neither MICA antibodies nor dsMICA were associated with acute rejection. However, interstitial fibrosis and tubular atrophy (IFTA) was significantly associated with MICA antibody positivity (OR=3.84, =0.009). In addition, the MFI value of dsMICA was significantly higher in patients with IFTA II or III than in patients without IFTA II or III ( =0.009). The association of MICA antibodies and dsMICA with high grade IFTA (grade II or III) was suggested. The MICA antibody and dsMICA might be useful indicators of chronic renal damage.</abstract><cop>United States</cop><pmid>32366564</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1550-8080
ispartof Annals of clinical and laboratory science, 2020-03, Vol.50 (2), p.247-252
issn 1550-8080
language eng
recordid cdi_proquest_miscellaneous_2398631438
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Allografts
Antibodies - blood
Antibody Formation
Female
Graft Rejection - etiology
Graft Rejection - pathology
Graft Survival - immunology
Histocompatibility Antigens Class I - immunology
Humans
Kidney Transplantation - adverse effects
Male
Middle Aged
Prognosis
Tissue Donors
title Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T05%3A56%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Associations%20of%20Anti-MHC%20Class%20I-related%20Chain%20A%20(MICA)%20Antibodies%20with%20Renal%20Allograft%20Outcomes&rft.jtitle=Annals%20of%20clinical%20and%20laboratory%20science&rft.au=Lee,%20Nuri&rft.date=2020-03&rft.volume=50&rft.issue=2&rft.spage=247&rft.epage=252&rft.pages=247-252&rft.eissn=1550-8080&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2398631438%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2398631438&rft_id=info:pmid/32366564&rfr_iscdi=true